New Modalities (Room 206AB)
Nancy Pryer, PhD
Ambagon Therapeutics, California, United States
Nancy K. Pryer, PhD – Ambagon Therapeutics
Paige Dickson, PhD (she/her/hers) – X-Chem
Sophia Katherine Berry, Dr – AstraZeneca
Daniel Nomura, PhD – University of California, Berkeley